Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 033179/0422 | |
| Pages: | 5 |
| | Recorded: | 06/10/2014 | | |
| Attorney Dkt #: | P-105 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
5
|
|
|
|
Patent #:
|
|
Issue Dt:
|
02/22/2005
|
Application #:
|
09846893
|
Filing Dt:
|
05/01/2001
|
|
Publication #:
|
|
Pub Dt:
|
06/20/2002
| | | | |
|
Title:
|
PHARMACEUTICAL COMPOSITIONS CONTAINING A GLYCOPEPTIDE ANTIBIOTIC AND A CYCLODEXTRIN
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
04/11/2006
|
Application #:
|
10930585
|
Filing Dt:
|
08/31/2004
|
|
Publication #:
|
|
Pub Dt:
|
02/03/2005
| | | | |
|
Title:
|
PHARMACEUTICAL COMPOSITIONS CONTAINING A GLYCOPEPTIDE ANTIBIOTIC AND A CYCLODEXTRIN
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
06/27/2006
|
Application #:
|
10931122
|
Filing Dt:
|
08/31/2004
|
|
Publication #:
|
|
Pub Dt:
|
02/10/2005
| | | | |
|
Title:
|
PHARMACEUTICAL COMPOSITIONS CONTAINING A GYCOPEPTIDE ANTIBIOTIC AND A CYCLODEXTRIN
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
06/09/2009
|
Application #:
|
11410597
|
Filing Dt:
|
04/25/2006
|
|
Publication #:
|
|
Pub Dt:
|
08/31/2006
| | | | |
|
Title:
|
PHARMACEUTICAL COMPOSITIONS CONTAINING A GLYCOPEPTIDE ANTIBIOTIC AND A CYCLODEXTRIN
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
04/17/2012
|
Application #:
|
12431940
|
Filing Dt:
|
04/29/2009
|
|
Publication #:
|
|
Pub Dt:
|
04/01/2010
| | | | |
|
Title:
|
PHARMACEUTICAL COMPOSITIONS CONTAINING A GLYCOPEPTIDE ANTIBIOTIC AND A CYCLODEXTRIN
|
|
|
Assignee
|
|
|
|
|
| 901 GATEWAY BOULEVARD |
| SOUTH SAN FRANCISCO, CALIFORNIA 94080 |
|
|
Correspondence name and address
|
| |
JEFFREY A. HAGENAH
|
| |
PATENT DEPARTMENT
|
| |
THERAVANCE BIOPHARMA US, INC.
|
| |
901 GATEWAY BOULEVARD
|
| |
SOUTH SAN FRANCISCO, CALIFORNIA 94080
|
Search Results as of:
05/29/2024 04:55 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
